Collection: Summer Collection
☀️ Summer Collection – Soak Up the Sun, Spread Hope
Welcome to our Summer Collection—where style meets purpose. From vibrant towels and swimwear to sun-ready accessories, every item in this collection is designed to brighten your season and bring hope to those affected by pancreatic cancer.
These feel-good finds don’t just elevate your summer—they help fund life-saving research through Sky Foundation. Whether you’re beach-bound, poolside, or chasing sunsets, your purchase makes a difference.
💜 A percentage of every sale supports pancreatic cancer research.
🏖️ What You’ll Find:
- Soft, absorbent towels with bold purple awareness designs
- Accessories for summer adventures, all designed with heart
- Comfortable, flattering swimwear made to move with you
Shop with purpose. Wear with pride. Make this summer one that gives back.

-
Awareness Towel (Dino Blue Waves)
Regular price $32.50 USDRegular priceUnit price / per -
Awareness Towel (Dino Big)
Regular price $32.50 USDRegular priceUnit price / per -
Awareness Towel (Purple Octo)
Regular price $32.50 USDRegular priceUnit price / per -
Awareness Towel (Purple Lux)
Regular price $32.50 USDRegular priceUnit price / per -
Awareness Towel (Purple Waves)
Regular price $32.50 USDRegular priceUnit price / per -
Awareness Towel (Striped)
Regular price $32.50 USDRegular priceUnit price / per -
Awareness Towel (Sky Ribbon)
Regular price $32.50 USDRegular priceUnit price / per -
Awareness Towel (Sky Big)
Regular price $32.50 USDRegular priceUnit price / per -
Awareness Towel (Purple Flower Sky)
Regular price $32.50 USDRegular priceUnit price / per -
Awareness Towel (Dinos)
Regular price $32.50 USDRegular priceUnit price / per -
Awareness Towel (Dinos Octo)
Regular price $32.50 USDRegular priceUnit price / per -
Awareness Towel (Dinos Striped)
Regular price $42.50 USDRegular priceUnit price / per
Latest News
View all-
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
-
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
-
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...